Suppr超能文献

B细胞转化中的转录调控回路。

Transcriptional circuits in B cell transformation.

作者信息

Hu Yeguang, Yoshida Toshimi, Georgopoulos Katia

机构信息

Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.

出版信息

Curr Opin Hematol. 2017 Jul;24(4):345-352. doi: 10.1097/MOH.0000000000000352.

Abstract

PURPOSE OF REVIEW

Loss of IKAROS in committed B cell precursors causes a block in differentiation while at the same time augments aberrant cellular properties, such as bone marrow stromal adhesion, self-renewal and resistance to glucocorticoid-mediated cell death. B cell acute lymphoblastic leukaemias originating from these early stages of B cell differentiation and associated with IKAROS mutations share a high-risk cellular phenotype suggesting that deregulation of IKAROS-based mechanisms cause a highly malignant disease process.

RECENT STUDIES

Recent studies show that IKAROS is critical for the activity of super-enhancers at genes required for pre-B cell receptor (BCR) signalling and differentiation, working either downstream of or in parallel with B cell master regulators such as EBF1 and PAX5. IKAROS also directly represses a cryptic regulatory network of transcription factors prevalent in mesenchymal and epithelial precursors that includes YAP1, TEAD1/2, LHX2 and LMO2, and their targets, which are not normally expressed in lymphocytes. IKAROS prevents not only expression of these 'extra-lineage' transcription factors but also their cooperation with endogenous B cell master regulators, such as EBF1 and PAX5, leading to the formation of a de novo for lymphocytes super-enhancer network. IKAROS coordinates with the Polycomb repression complex (PRC2) to provide stable repression of associated genes during B cell development. However, induction of regulatory factors normally repressed by IKAROS starts a feed-forward loop that activates de-novo enhancers and elevates them to super-enhancer status, thereby diminishing PRC2 repression and awakening aberrant epithelial-like cell properties in B cell precursors.

SUMMARY

Insight into IKAROS-based transcriptional circuits not only sets new paradigms for cell differentiation but also provides new approaches for classifying and treating high-risk human B-ALL that originates from these early stages of B cell differentiation.

摘要

综述目的

在已定向的B细胞前体中IKAROS缺失会导致分化受阻,同时增强异常细胞特性,如骨髓基质黏附、自我更新以及对糖皮质激素介导的细胞死亡的抗性。源自B细胞分化早期阶段且与IKAROS突变相关的B细胞急性淋巴细胞白血病具有高风险细胞表型,这表明基于IKAROS的机制失调会导致高度恶性的疾病进程。

近期研究

近期研究表明,IKAROS对于前B细胞受体(BCR)信号传导和分化所需基因的超级增强子活性至关重要,其作用于EBF1和PAX5等B细胞主要调节因子的下游或与之平行。IKAROS还直接抑制间充质和上皮前体中普遍存在的包括YAP1、TEAD1/2、LHX2和LMO2及其靶标的转录因子的隐秘调控网络,这些因子通常不在淋巴细胞中表达。IKAROS不仅阻止这些“额外谱系”转录因子的表达,还阻止它们与内源性B细胞主要调节因子(如EBF1和PAX5)的合作,从而导致淋巴细胞超级增强子网络的重新形成。IKAROS与多梳抑制复合体(PRC2)协同作用,在B细胞发育过程中对相关基因提供稳定的抑制。然而,诱导通常被IKAROS抑制的调节因子会启动一个前馈环,激活新生增强子并将其提升到超级增强子状态,从而削弱PRC2的抑制作用并唤醒B细胞前体中异常的上皮样细胞特性。

总结

对基于IKAROS的转录回路的深入了解不仅为细胞分化设定了新范式,还为源自B细胞分化早期阶段的高危人类B-ALL的分类和治疗提供了新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2386/5701664/fd44a53b65b8/nihms892617f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验